WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005105832) BIOLOGICALLY ACTIVE PEPTIDE VAPEEHPTLLTEAPLNPK DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/105832    International Application No.:    PCT/EP2005/004419
Publication Date: 10.11.2005 International Filing Date: 25.04.2005
Chapter 2 Demand Filed:    29.06.2006    
IPC:
C07K 14/47 (2006.01), A61K 38/04 (2006.01), A61K 38/17 (2006.01), C07K 5/062 (2006.01), C07K 5/093 (2006.01), C07K 5/103 (2006.01), C07K 7/06 (2006.01)
Applicants: CMS PEPTIDES PATENT HOLDING COMPANY LIMITED [--/--]; Trident Chambers, P.O. Box 146, Road Town, Tortola (VG) (For All Designated States Except US).
SENIOR, Alan, Murray [GB/GB]; (GB) (AG only).
WONG, Wai, Ming [CN/CN]; (CN) (For US Only).
LAM, Kong [CN/CN]; (CN) (For US Only)
Inventors: WONG, Wai, Ming; (CN).
LAM, Kong; (CN)
Agent: ROQUES, Sarah, Elizabeth; J. A. Kemp & Co., 14 South Square, Gray's Inn, London WC1R 5JJ (GB)
Priority Data:
60/566,455 28.04.2004 US
Title (EN) BIOLOGICALLY ACTIVE PEPTIDE VAPEEHPTLLTEAPLNPK DERIVATIVES
(FR) DERIVES VAPEEHPTLLTEAPLNPK DE PEPTIDES BIOLOGIQUEMENT ACTIFS
Abstract: front page image
(EN)Peptides derived from the peptide CMS-010, which has the formula VAPEEHPTLLTEAPLNPK, are disclosed with their use as pharmaceutical compositions. A method is also disclosed for making a pharmaceutical composition comprising providing a peptide derived from CMS-010 and mixing said peptide with a pharmaceutical acceptable carrier.
(FR)L'invention concerne des peptides issus du peptide CMS-010, de formule VAPEEHPTLLTEAPLNPK, ainsi que l'utilisation de ces peptides en tant que compositions pharmaceutiques. L'invention concerne également un procédé de préparation d'une composition pharmaceutique. Ce procédé consiste à obtenir un peptide issu de CMS-010 et à mélanger ledit peptide à un excipient pharmaceutiquement acceptable.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)